DiGiovanna MP - Search Results

1

Phosphorylated/activated HER2 as a marker of clinical resistance to single agent taxane chemotherapy for metastatic breast cancer.

Modi S, DiGiovanna MP, Lu Z, Moskowitz C, Panageas KS, Van Poznak C, Hudis CA, Norton L, Tan L, Stern DF, Carter D, Seidman AD. Modi S, et al. Among authors: digiovanna mp. Cancer Invest. 2005;23(6):483-7. doi: 10.1080/07357900500201301. Cancer Invest. 2005. PMID: 16203655

2

Activation state-specific monoclonal antibody detects tyrosine phosphorylated p185neu/erbB-2 in a subset of human breast tumors overexpressing this receptor.

DiGiovanna MP, Stern DF. DiGiovanna MP, et al. Cancer Res. 1995 May 1;55(9):1946-55. Cancer Res. 1995. PMID: 7728765

3

Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours.

DiGiovanna MP, Carter D, Flynn SD, Stern DF. DiGiovanna MP, et al. Br J Cancer. 1996 Sep;74(5):802-6. doi: 10.1038/bjc.1996.439. Br J Cancer. 1996. PMID: 8795585 Free PMC article.

4

Active signaling by Neu in transgenic mice.

DiGiovanna MP, Lerman MA, Coffey RJ, Muller WJ, Cardiff RD, Stern DF. DiGiovanna MP, et al. Oncogene. 1998 Oct 8;17(14):1877-84. doi: 10.1038/sj.onc.1202091. Oncogene. 1998. PMID: 9778054

5

Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu): a study of incidence and correlation with outcome in breast cancer.

Thor AD, Liu S, Edgerton S, Moore D 2nd, Kasowitz KM, Benz CC, Stern DF, DiGiovanna MP. Thor AD, et al. Among authors: digiovanna mp. J Clin Oncol. 2000 Sep 15;18(18):3230-9. doi: 10.1200/JCO.2000.18.18.3230. J Clin Oncol. 2000. PMID: 10986055

6

Adenoid cystic carcinoma: a retrospective clinical review.

Khan AJ, DiGiovanna MP, Ross DA, Sasaki CT, Carter D, Son YH, Haffty BG. Khan AJ, et al. Among authors: digiovanna mp. Int J Cancer. 2001 Jun 20;96(3):149-58. doi: 10.1002/ijc.1013. Int J Cancer. 2001. PMID: 11410883 Free article. Review.

7

Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors.

Claus EB, Chu P, Howe CL, Davison TL, Stern DF, Carter D, DiGiovanna MP. Claus EB, et al. Among authors: digiovanna mp. Exp Mol Pathol. 2001 Jun;70(3):303-16. doi: 10.1006/exmp.2001.2366. Exp Mol Pathol. 2001. PMID: 11418009

8

Molecular marker expression in oral and oropharyngeal squamous cell carcinoma.

Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, Haffty BG. Smith BD, et al. Among authors: digiovanna mp. Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):780-5. Arch Otolaryngol Head Neck Surg. 2001. PMID: 11448349

9

Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.

Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG. Khan AJ, et al. Among authors: digiovanna mp. Clin Cancer Res. 2002 Feb;8(2):540-8. Clin Cancer Res. 2002. PMID: 11839675

10

Active signaling by HER-2/neu in a subpopulation of HER-2/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates.

DiGiovanna MP, Chu P, Davison TL, Howe CL, Carter D, Claus EB, Stern DF. DiGiovanna MP, et al. Cancer Res. 2002 Nov 15;62(22):6667-73. Cancer Res. 2002. PMID: 12438265

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

63 results

Search Page